Pathophysiology of chronic kidney disease-mineral and bone disorder

被引:34
|
作者
Mac Way, Fabrice [1 ,2 ,3 ]
Lessard, Myriam [1 ,2 ,4 ]
Lafage-Proust, Marie-Helene [1 ,2 ]
机构
[1] Univ Lyon, INSERM, U1059, F-42023 St Etienne 2, France
[2] CHU St Etienne, F-42055 St Etienne 2, France
[3] Hotel Dieu Quebec, Nephrol, Quebec City, PQ G1R 2J6, Canada
[4] Hop Sacre Coeur Montreal, Ouest Montreal, PQ H4J 1C5, Canada
关键词
Parathyroid hormone; FGF23; Bone biopsy; Bone turnover; Osteomalacia; Secondary hyperparathyroidism; HYPERPLASTIC PARATHYROID-GLANDS; RENAL OSTEODYSTROPHY; CKD PATIENTS; SECONDARY HYPERPARATHYROIDISM; DEPRESSED EXPRESSION; DOWN-REGULATION; RECEPTOR; CALCIUM; FGF23; PTH;
D O I
10.1016/j.jbspin.2012.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) alters the metabolism of several minerals, thereby inducing bone lesions and vessel-wall calcifications that can cause functional impairments and excess mortality. The histological bone abnormalities seen in CKD, known as renal osteodystrophy, consist of alterations in the bone turnover rate, which may be increased (osteitis fibrosa [OF]) or severely decreased (adynamic bone disease [AD]); abnormal mineralization (osteomalacia [OM]), and bone loss. Secondary hyperparathyroidism is related to early phosphate accumulation (responsible for FGF23 overproduction by bone tissue), decreased calcitriol production by the kidneys, and hypocalcemia. Secondary hyperparathyroidism is associated with OF. Other factors that affect bone include acidosis, chronic inflammation, nutritional deficiencies, and iatrogenic complications. (C) 2012 Published by Elsevier Masson SAS on behalf of the Societe Francaise de Rhumatologie.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 50 条
  • [41] Current Concepts and Management Strategies in Chronic Kidney Disease-Mineral and Bone Disorder
    Chauhan, Veeraish
    Kelepouris, Ellie
    Chauhan, Nishtha
    Vaid, Megha
    [J]. SOUTHERN MEDICAL JOURNAL, 2012, 105 (09) : 479 - 485
  • [42] The role of activin: the other side of chronic kidney disease-mineral bone disorder?
    Cianciolo, Giuseppe
    La Manna, Gaetano
    Capelli, Irene
    Gasperoni, Lorenzo
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 966 - 974
  • [43] Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?
    Tan, Sven-Jean
    Cai, Michael M. X.
    [J]. NEPHROLOGY, 2017, 22 : 14 - 18
  • [44] The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome
    Lingbo Zhang
    Isaac Kumi Adu
    Haifeng Zhang
    Jiancheng Wang
    [J]. International Urology and Nephrology, 2023, 55 : 2527 - 2538
  • [45] Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease
    Parker, Valerie J.
    Rudinsky, Adam J.
    Benedict, Jason A.
    Beizaei, Azadeh
    Chew, Dennis J.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2020, 34 (06) : 2497 - 2506
  • [46] The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome
    Zhang, Lingbo
    Adu, Isaac Kumi
    Zhang, Haifeng
    Wang, Jiancheng
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (10) : 2527 - 2538
  • [47] Chronic kidney disease-mineral bone disorder: an update on the pathology and cranial manifestations
    Raubenheimer, Erich J.
    Noffke, Claudia E. E.
    Hendrik, Hilde D.
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (04) : 239 - 243
  • [48] Chronic kidney disease-mineral and bone disorder: Guidelines for diagnosis, treatment, and management
    Moschella, Carla
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (07): : 21 - 29
  • [49] Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
    Komaba, Hirotaka
    Tanaka, Motoko
    Fukagawa, Masafumi
    [J]. INTERNAL MEDICINE, 2008, 47 (11) : 989 - 994
  • [50] CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER IN THE ELDERLY PERITONEAL DIALYSIS PATIENT
    Heaf, James Goya
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (06): : 640 - 644